The hypothalamus and migraine: A potential new therapeutic avenue
Recent discoveries have shifted the attention of migraine pathophysiology from the brainstem to the hypothalamus. In this interview, Dr Anna Andreou explains how understanding the hypothalamus’ role as a migraine trigger can help identify specific parts of the brain for future treatment development.
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now